C20H18F2N3O5.Na
Neat
441.36
+5°C
Room Temperature
2H-Pyrido[1, 2:4, 5]pyrazino[2, 1-b][1, 3]oxazine-9-carboxamide, N-[(2, 4-difluorophenyl)methyl]-3, 4, 6, 8, 12, 12a-hexahydro-7-hydroxy-4-methyl-6, 8-dioxo-, sodium salt (1:1), (4R, 12aS)-, Dolutegravir sodium, Dolutegravir sodium salt, GSK 1349572A and GSK 1349572A
[Na+].C[C@@H]1CCO[C@H]2CN3C=C(C(=O)NCc4ccc(F)cc4F)C(=O)C(=C3C(=O)N12)[O-]
sodium;(4R, 12aS)-9-[(2, 4-difluorophenyl)methylcarbamoyl]-4-methyl-6, 8-dioxo-3, 4, 12, 12a-tetrahydro-2H-pyrido[5, 6]pyrazino[2, 6-b][1 and 3]oxazin-7-olate